DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Novo Nordisk (NYSE: NVO)

55.73 -0.43 (-0.77%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVO $55.73 -0.77%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.76
Previous Close $56.16
Daily Range $55.29 - $55.87
52-Week Range $41.72 - $60.34
Market Cap $147.7B
P/E Ratio 0.00
Dividend (Yield) $0.73 (0.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 894,765
Average Daily Volume 1,393,857
Current FY EPS $1.89




Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website:

News & Commentary Rss Feed

Is This Novo Nordisk's Next Blockbuster Drug?

Novo recently presented terrific data on its pipeline drug IDegLira, but U.S. approval is still far from certain. If it can gain approval, will it be meaningful to the company?

Novo's Oral GLP-1 Looks Sweeter

Benzinga's Top Initiations

Health Care Sector Update for 08/28/2015: NVO, GHDX, ANIK

Novo Nordisk to Start PIONEER Program on Semaglutide

3 Stocks Pushing The Health Care Sector Lower

Cardiovascular Radiance For Jardiance

Jim Simons Betting On Microsoft, Colgate-Palmolive, Novo Nordisk & Alaska Air

3 Stocks Pushing The Drugs Industry Higher

US Stock Futures Slip Ahead Of Economic Data

Novo Nordisk A/S (NVO) CEO Lars Rebien Sorensen on Q2 2015 Results - Earnings Call Transcript

See More NVO News...

NVO's Top Competitors

NVO $55.73 (-0.77%)
Current stock: NVO
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY